Trials / Completed
CompletedNCT01034865
Risk Factors and Molecular Genomics of U.S. Patients With Chronic Liver Disease and Hepatocellular Cancer
Risk Factors and Molecular Genomics for Hepatocellular Carcinoma in U.S. Patients With Chronic Liver Disease: A Case Control Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 750 (actual)
- Sponsor
- Stanford University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To identify risk factors for the development and diagnosis of hepatocellular CA in patients with chronic hepatitis C and to use the data to ultimately develop an effective screening program.
Conditions
Timeline
- Start date
- 2001-05-01
- Primary completion
- 2009-06-01
- Completion
- 2009-06-01
- First posted
- 2009-12-18
- Last updated
- 2017-05-01
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01034865. Inclusion in this directory is not an endorsement.